The Progress in Molecular Transport and Therapeutic Development in Human Blood-Brain Barrier Models in Neurological Disorders
© 2024. The Author(s)..
The blood-brain barrier (BBB) is responsible for maintaining homeostasis within the central nervous system (CNS). Depending on its permeability, certain substances can penetrate the brain, while others are restricted in their passage. Therefore, the knowledge about BBB structure and function is essential for understanding physiological and pathological brain processes. Consequently, the functional models can serve as a key to help reveal this unknown. There are many in vitro models available to study molecular mechanisms that occur in the barrier. Brain endothelial cells grown in culture are commonly used to modeling the BBB. Current BBB platforms include: monolayer platforms, transwell, matrigel, spheroidal, and tissue-on-chip models. In this paper, the BBB structure, molecular characteristic, as well as its dysfunctions as a consequence of aging, neurodegeneration, or under hypoxia and neurotoxic conditions are presented. Furthermore, the current modelling strategies that can be used to study BBB for the purpose of further drugs development that may reach CNS are also described.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Cellular and molecular neurobiology - 44(2024), 1 vom: 16. Apr., Seite 34 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Korszun-Karbowniczak, Joanna [VerfasserIn] |
---|
Links: |
---|
Themen: |
BBB permeability |
---|
Anmerkungen: |
Date Completed 18.04.2024 Date Revised 25.04.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10571-024-01473-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM371164257 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM371164257 | ||
003 | DE-627 | ||
005 | 20240425234904.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240417s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10571-024-01473-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1386.xml |
035 | |a (DE-627)NLM371164257 | ||
035 | |a (NLM)38627312 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Korszun-Karbowniczak, Joanna |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Progress in Molecular Transport and Therapeutic Development in Human Blood-Brain Barrier Models in Neurological Disorders |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.04.2024 | ||
500 | |a Date Revised 25.04.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a The blood-brain barrier (BBB) is responsible for maintaining homeostasis within the central nervous system (CNS). Depending on its permeability, certain substances can penetrate the brain, while others are restricted in their passage. Therefore, the knowledge about BBB structure and function is essential for understanding physiological and pathological brain processes. Consequently, the functional models can serve as a key to help reveal this unknown. There are many in vitro models available to study molecular mechanisms that occur in the barrier. Brain endothelial cells grown in culture are commonly used to modeling the BBB. Current BBB platforms include: monolayer platforms, transwell, matrigel, spheroidal, and tissue-on-chip models. In this paper, the BBB structure, molecular characteristic, as well as its dysfunctions as a consequence of aging, neurodegeneration, or under hypoxia and neurotoxic conditions are presented. Furthermore, the current modelling strategies that can be used to study BBB for the purpose of further drugs development that may reach CNS are also described | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a BBB permeability | |
650 | 4 | |a Blood-brain barrier (BBB) | |
650 | 4 | |a Hypoxia | |
650 | 4 | |a Tight junctions | |
700 | 1 | |a Krysiak, Zuzanna Joanna |e verfasserin |4 aut | |
700 | 1 | |a Saluk, Joanna |e verfasserin |4 aut | |
700 | 1 | |a Niemcewicz, Marcin |e verfasserin |4 aut | |
700 | 1 | |a Zdanowski, Robert |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cellular and molecular neurobiology |d 1993 |g 44(2024), 1 vom: 16. Apr., Seite 34 |w (DE-627)NLM012620580 |x 1573-6830 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2024 |g number:1 |g day:16 |g month:04 |g pages:34 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10571-024-01473-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2024 |e 1 |b 16 |c 04 |h 34 |